¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"dihydro"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
À̰ÍÀ» ¿øÇϼ̽À´Ï±î?
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 2
DHbetaE Dihydro-beta-erythroidine
DHO Dihydro-ouabain
DHTP dihydro-testosterone propionate
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
dihydroergocristine An ergot alkaloid derivative prepared by the hydrogenation of ergocristine and less toxic than the latter.
See: dihydroergotoxine mesylate.
(05 Mar 2000)
dihydroergocryptine An ergot alkaloid derivative prepared by the hydrogenation of ergocryptine and less toxic than the latter.
See: dihydroergotoxine mesylate.
(05 Mar 2000)
dihydroergotamine <chemical> 9,10-dihydro-12'-hydroxy-2'-methyl-5'-(phenylmethyl)ergotaman-3',6',18-trione. A derivative of ergotamine prepared by the catalytic hydrogenation of ergotamine. It is used as a vasoconstrictor, specifically for the therapy of migraine.
Pharmacological action: analgesics, non-narcotic, vasoconstrictor agents.
Chemical name: Ergotaman-3',6',18-trione, 9,10-dihydro-12'-hydroxy-2'-methyl-5'-(phenylmethyl)-, (5'alpha,10alpha)-
(12 Dec 1998)
dihydroergotoxine <chemical> Dihydroergotoxine. A mixture of three different ergotaman-3',6',18-triones, dihydroergocornine, dihydroergocristine, and dihydroergocryptine. It has been proposed to be a neuroprotective agent and a nootropic agent. The mechanism of its therapeutic actions is not clear, but it can act as an alpha-adrenergic antagonist and a dopamine agonist. The combination of the methanesulfonate salts of these alkaloids is dihydroergotoxine mesylate (see ergoloid mesylates).
Pharmacological action: adrenergic alpha-antagonists, dopamine agonists, neuroprotective agents, nootropic agents.
Chemical name: Ergotoxine, dihydro-
(12 Dec 1998)
dihydroergotoxine mesylate A mixture of dihydroergocornine methanesulfate, dihydroergocristine methanesulfate, and dihydroergocryptine methane sulfate; used as an alpha-adrenergic blocking agent for relief of cardiovascular insufficiency.
(05 Mar 2000)
dihydroflavanol 4-reductase <enzyme> Isolated from flowers of dahlia varibilis; requires NADPH as a cofactor; catalyses the transfer of pro-s hydrogen of NADPH to the substrate; pH optima 6.0 for flavanones and 6.8 for dihydroflavonols
Registry number: EC 1.1.1.-
Synonym: 3-hydroxyflavanone 4-reductase, dhf reductase, dihydroflavonol-4-reductase, dihydroflavanol reductase
(26 Jun 1999)
dihydrofolate monooxygenase <enzyme> 7,8-dihydrofolate plus 1/2 o2 gives 7,8-dihydropterin-6-aldehyde plus p-aminobenzoylglutamate
Registry number: EC 1.13.-
(26 Jun 1999)
dihydrofolate reductase <enzyme> An enzyme involved in the biosynthesis of folic acid coenzymes, that transfers hydrogen from NADP to dihydrofolate, yielding tetrahydrofolic acid. Inhibitors can be used as antimicrobial and anticancer drugs. Standard source is liver and the enzyme is used to assay dihydrofolate.
(18 Nov 1997)
dihydrogen phosphate One-third-neutralised phosphoric acid; e.g., NaH2PO4, KH2PO4.
Disodium phosphate, na2HPO4.
(05 Mar 2000)
dihydrogeodin oxidase <enzyme> Copper-containing enzyme which converts dihydrogeodin to (+)-geodin by an intramolecular phenol oxidative coupling reaction; isolated from aspergillus terreus
Registry number: EC 1.10.3.-
(26 Jun 1999)
dihydrolipoamide acetyltransferase <enzyme> Part of the pyruvate dehydrogenase complex; acef isolated from e. Coli
Registry number: EC 2.3.1.12
Synonym: dihydrolipoyl transacetylase, lipoate acetyltransferase, dihydrolipoyl acetyltransferase, acef gene product
(26 Jun 1999)
dihydrolipoamide acyltransferase <enzyme> Component of branched-chain 2-oxo acid dehydrogenase multienzyme complex; mutation in this (e2) catalytic subunit identifies type II maple syrup urine disease
Registry number: EC 2.3.1.-
Synonym: dihydrolipoyl transacylase, branched chain acyltransferase, e2 transacylase
(26 Jun 1999)
dihydrolipoamide dehydrogenase <enzyme> An enzyme oxidizing dihydrolipoamide at the expense of NAD+; completes the oxidative decarboxylation of pyruvate; a part of several enzyme complexes (e.g., alpha-ketoglutarate dehydrogenase complex). Decreased activity leads to neuronal loss in brain resulting in psychomotor retardation.
Synonym: coenzyme factor, lipoamide dehydrogenase, lipoamide reductase (NADH), lipoyl dehydrogenase.
(05 Mar 2000)
dihydrolipoamide succinyltransferase <enzyme> Component of the ketoglutarate dehydrogenase complex
Registry number: EC 2.3.1.61
Synonym: succinyl-CoA-dihydrolipoate-s-succinyltransferase, dihydrolipoyl transsuccinylase, lipoyl transsuccinylase, lipoate succinyltransferase, lipoamide succinyltransferase, succinyl-coenzyme a-dihydrolipoate-s-succinyltransferase
(26 Jun 1999)
dihydrolipoic acid Reduced lipoic acid, formed by cleavage of the -S-S- bond as a result of the acceptance of two hydrogens.
Compare: lipoic acid.
(05 Mar 2000)
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 5 ÆäÀÌÁö: 2
  • Dihydroergocryptine - »õâ A 9,10alpha-dihydro derivative of ERGOTAMINE that contains an isopropyl sidechain at the 2' position and an alpha-isobutyl sidechain at 5'alpha position of the molecule.
    Synonyms : Almirid, Cripar, Desitin Brand of Dihydroergocryptine Monomesylate, Dihydroergocryptine Monomesylate, Dihydroergokryptine Mesylate, Dihydroergokryptine Monomesylate, Hormosan Brand of Dihydroergocryptine Monomesylate, Mesylate, Dihydroergocryptine
  • Dihydroergotamine - »õâ A 9,10alpha-dihydro derivative of ERGOTAMINE. It is used as a vasoconstrictor, specifically for the therapy of MIGRAINE DISORDERS.
    Synonyms : Agit, Aliud Brand of Dihydroergotamine Mesylate, Alpharma Brand of Dihydroergotamine Mesylate, Angionorm, Anto Brand of Dihydroergotamine Mesylate, Clavigrenin, D-Tamin retard L.U.T., D.H.E. 45, DET MS, DHE-45, DHE-Puren, DHE-ratiopharm, Dihydergot, Dihytamin, Tamik
  • Dihydroergotoxine - »õâ A mixture of three different hydrogenated derivatives of ERGOTAMINE: DIHYDROERGOCORNINE; DIHYDROERGOCRISTINE; and DIHYDROERGOCRYPTINE. Dihydroergotoxine has been proposed to be a neuroprotective agent and a nootropic agent. The mechanism of its therapeutic actions is not clear, but it can act as an alpha-adrenergic antagonist and a dopamine agonist. The methanesulfonate salts of this mixture of alkaloids are called ERGOLOID MESYLATES.
    Synonyms : Dihydroergotoxin, Alkaloids, Hydrogenated Ergot, Hydrogenated Ergot Alkaloids
  • Dihydrolipoamide Dehydrogenase - »õâ A flavoprotein containing oxidoreductase that catalyzes the reduction of lipoamide by NADH to yield dihydrolipoamide and NAD+. The enzyme is a component of several MULTIENZYME COMPLEXES.
    Synonyms : Diaphorase (Lipoamide Dehydrogenase), Dihydrolipoyl Dehydrogenase, Glycine Decarboxylase Complex L-Protein, L-Protein, Glycine Decarboxylase Complex, Lipoamide Dehydrogenase, Valine, Lipoic Acid Dehydrogenase, Lipoyl Dehydrogenase, Dehydrogenase, Lipoamide
  • Dihydrolipoyllysine-Residue Acetyltransferase - »õâ An enzyme that catalyzes the acetyltransferase reaction using ACETYL CoA as an acetyl donor and dihydrolipoamide as acceptor to produce COENZYME A (CoA) and S-acetyldihydrolipoamide. It forms the (E2) subunit of the PYRUVATE DEHYDROGENASE COMPLEX.
    Synonyms : Acetyl-CoA-Dihydrolipoamide S-Acetyltransferase, Dihydrolipoamide Acetyltransferase, Dihydrolipoamide S-Acetyltransferase, Dihydrolipoyl Acetyltransferase, Dihydrolipoyl Transacetylase, Lipoate Acetyltransferase, Pyruvate Dehydrogenase Complex E2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 5 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 10 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
À¯³ë°ñÁ¤ - »õâ
Çѹ̾àǰ
A21401871 Dihydroergocristine Methanesulfonate
Àü¹®ÀǾàǰ | »èÁ¦
µð¶ôÁ¤ - »õâ
°æµ¿Á¦¾à
A17602291 Dihydroergocristine Methanesulfonate
Àü¹®ÀǾàǰ | »èÁ¦
µñÅæÁ¤ - »õâ
Áø¾çÁ¦¾à
A10702111 Dihydroergocristine Methanesulfonate
Àü¹®ÀǾàǰ | »èÁ¦
À¯ÅØÁ¤ - »õâ
¼¼Á¾Á¦¾à
A21150661 Dihydroergocristine Methanesulfonate
Àü¹®ÀǾàǰ | »èÁ¦
À¯·ÎµòÁ¤ - »õâ
´ëÇÑ´ºÆÊ
A60650061 Dihydroergocristine Methanesulfonate
Àü¹®ÀǾàǰ | »èÁ¦
±â´ÐÁÖ1mg - »õâ
´ë¿øÁ¦¾à
A12850821 Dihydroergotamine Mesylate
Àü¹®ÀǾàǰ | »èÁ¦ | ºÐ¾÷¿¹¿ÜÀǾàǰ
ºô¸®¿ø¿¬Áúݼ¿ - »õâ
´Ù¸²¹ÙÀÌ¿ÀÅØ
A11250571 Dihydroxydibutylether
ÀϹÝÀǾàǰ | ºñ±Þ¿©
°¡¸®½º¿¬Áúݼ¿500mg - »õâ
ÇѺÒÁ¦¾à
A22551401 Dihydroxydibutylether
ÀϹÝÀǾàǰ | ±Þ¿©
À̽ºÄɵôÁÖ - »õâ
ÇÑÈ­Á¦¾à
A15300591 Dihydroergocristine Methanesulfonate, Raubasine
Àü¹®ÀǾàǰ | »èÁ¦
ÇÏÀ̺ô¿¬Áúݼ¿ - »õâ
½ÅÈ£Á¦¾à
Dihydroxydibutylether
ÀϹÝÀǾàǰ | ºñ±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 8 ÆäÀÌÁö: 2
  • Dihydrotachysterol Oral - »õâ
  • Dihydrotestosterone Prop(Bulk) Misc - »õâ
  • Dihydrotestosterone Propionate Misc - »õâ
  • Dihydroxcodeine Compound Oral - »õâ
  • Dihydroxyacetone Top - »õâ
  • Dihydroxyacetone-Emollient Top - »õâ
  • Dihydroxyacetone-Witch Hazel Top - »õâ
  • Dihydroxyaluminum Sod Carb Oral - »õâ
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
dihydrotestosterone (DHT) (5 alpha-dihydrotestosterone) the male hormone which is most active in the prostate; it is made when an enzyme (5 alpha reductase) in the prostate stimulates the transformation of testosterone to DHT
Ãâó: ppml.acor.org/GLOSSARY.html
dihydrocodeine Pain relief drug.
Ãâó: www.bbc.co.uk/holbycity/glossary/d.shtml
dihydrotestosterone a conversion of testosterone that is considered to be an aging-bio-marker. Among its affects are the appearance of body-hair, the loss of scalp hair and the onset of prostate gland problems.
Ãâó: www.medaus.com/p/147.html
dihydroxyacetone A self-tanning agent used in cosmetics.
Ãâó: allindiansite.com/home/beauty/beauty_glossary.html
dihydrotestosterone is a male hormone that is suggested to be the main cause for the miniaturisation of the hair follicle and for hair loss. DHT is formed when the male hormone testosterone interacts with the enzyme 5-alpha reductase.
Ãâó: www.americanhairloss.org/hair_loss_glossary/
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 3 ÆäÀÌÁö: 2
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á